NX Prenatal Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

NX Prenatal General Information

Description

Developer of diagnostic assays designed to detect, monitor, and manage pregnancy-related complications. The company's assays provide advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids and detect biomarkers for prenatal risk assessment, enabling physicians to intervene in a timely manner and reduce the likelihood of preterm birth or minimize the complications that can arise for both the child and the mother.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4800 Fournace Place
  • Suite BW28
  • Bellaire, TX 77401
  • United States
+1 (801)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 4800 Fournace Place
  • Suite BW28
  • Bellaire, TX 77401
  • United States
+1 (801)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NX Prenatal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC (Series A3) 21-Aug-2023 Completed Generating Revenue
8. Accelerator/Incubator 14-Oct-2022 Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC (Series A3) 04-Aug-2021 Completed Generating Revenue
5. Later Stage VC 20-Nov-2020 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Debt - General 20-Oct-2016 Completed Generating Revenue
2. Early Stage VC (Series A2) 12-Feb-2016 $25K $775K Completed Generating Revenue
1. Early Stage VC (Series A1) 29-Jan-2014 $750K $750K Completed Product Development
To view NX Prenatal’s complete valuation and funding history, request access »

NX Prenatal Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A3 Prime
Series A3
Series A2 454,545 $0.000100 8% $6.6 $6.6 1x $6.6 6.96%
Series A1 421,001 $0.000100 8% $6 $6 1x $6 6.45%
To view NX Prenatal’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NX Prenatal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnostic assays designed to detect, monitor, and manage pregnancy-related complications. The company's as
Biotechnology
Bellaire, TX
9 As of 2025

Birmingham, AL
 

Hillsboro, OR
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NX Prenatal Competitors (3)

One of NX Prenatal’s 3 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CirculoGene Venture Capital-Backed Birmingham, AL
Modality Dx Venture Capital-Backed Hillsboro, OR
BioGenex Laboratories Corporation Fremont, CA
You’re viewing 3 of 3 competitors. Get the full list »

NX Prenatal Patents

NX Prenatal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023150726-A2 Three-tiered risk stratification for spontaneous preterm birth Inactive 03-Feb-2022
WO-2023150726-A3 Three-tiered risk stratification for spontaneous preterm birth Inactive 03-Feb-2022
JP-2024546438-A Methods for preparing and analyzing samples for biomarkers associated with placenta accreta Pending 11-Nov-2021
EP-4430406-A2 Methods of preparing and analyzing samples for biomarkers associated with placenta accreta Pending 11-Nov-2021
EP-4430406-A4 Methods of preparing and analyzing samples for biomarkers associated with placenta accreta Pending 11-Nov-2021 G01N30/88
To view NX Prenatal’s complete patent history, request access »

NX Prenatal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NX Prenatal Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
Angel (individual) Minority
BlueTree Allied Angels Angel Group Minority
Angel (individual) Minority
Golden Seeds Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

NX Prenatal FAQs

  • When was NX Prenatal founded?

    NX Prenatal was founded in 2014.

  • Where is NX Prenatal headquartered?

    NX Prenatal is headquartered in Bellaire, TX.

  • What is the size of NX Prenatal?

    NX Prenatal has 9 total employees.

  • What industry is NX Prenatal in?

    NX Prenatal’s primary industry is Biotechnology.

  • Is NX Prenatal a private or public company?

    NX Prenatal is a Private company.

  • What is NX Prenatal’s current revenue?

    The current revenue for NX Prenatal is .

  • How much funding has NX Prenatal raised over time?

    NX Prenatal has raised $8.97M.

  • Who are NX Prenatal’s investors?

    Johnson & Johnson Innovation - JLABS, , BlueTree Allied Angels, , and Golden Seeds are 5 of 10 investors who have invested in NX Prenatal.

  • Who are NX Prenatal’s competitors?

    CirculoGene, Modality Dx, and BioGenex Laboratories are competitors of NX Prenatal.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process